Inclusion criteria in BE studies [Design Issues]

posted by jag009  – NJ, 2020-05-25 09:43 (1290 d 22:25 ago) – Posting: # 21460
Views: 3,270

Hi,

❝ In BE studies, in case the participants are both males and females, should the ratio between them be 1:1 or any ratio is accepted, also for randomization procedure is there any special requirements in case both included?


You should aim for 1:1 in the protocol but say at least 60:40 split (you can try 70:30 if you are desperate). I do that on my protocols for many yrs and no problem w FDA.

You should randomize w gender as well. I had one CRO who put the first 10 as males and then last 10 as females, lol. No I did not find that funny when I spoke w them.

J

Complete thread:

UA Flag
Activity
 Admin contact
22,818 posts in 4,784 threads, 1,634 registered users;
32 visitors (0 registered, 32 guests [including 9 identified bots]).
Forum time: 07:08 CET (Europe/Vienna)

The greatest obstacle to discovery is not ignorance 
it is the illusion of knowledge.    Daniel J. Boorstin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5